Thus, it has been seen that the administration of ABX-IL-8 to mice carrying xenografts of bladder cancer decreases their tendency to metastasize and progress, as it also happens in similar models of melanoma and prostate cancer [18, 78]. Here, CXCL8 is linked to urinary bladder carcinoma.